Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DANA is positioned as “The Brain Thermometer,” an FDA-cleared neurocognitive assessment tool designed to quickly detect and quantify changes in cognitive performance. Through mobile-based, self-administered, gamified tests, it can collect cognitive and psychological assessment data in as little as 5 minutes. Its target users include clinicians, patients, researchers, and healthcare technology use cases.
Based on the site content, DANA’s core capabilities focus on measuring cognitive resilience, processing speed, and changes in mental state. It can provide an at-a-glance top-level score, as well as detailed trial-by-trial data, and generate visualized trends over time. It supports frequent repeated testing, emphasizes sensitivity to subtle cognitive changes, and uses public-domain tests backed by scientific literature to reduce the impact of demographic factors and practice effects. The product is available on iOS and Android and supports both in-clinic and remote self-administration.
The website does not disclose plans, pricing, a free tier, or trial policy; it only provides an option to schedule a demo. Compliance information is relatively clear: DANA has received FDA clearance and states that it is HIPAA-compliant. It also mentions that reimbursement may be available through multiple payers, but does not list reimbursement conditions. No detailed information is provided on third-party integrations, APIs, developer support, team permissions, institutional admin dashboards, or cloud/self-hosted deployment options.
The main strengths are its strong medical compliance credentials and its suitability for high-frequency, longitudinal cognitive monitoring in clinical settings. The mobile self-guided workflow lowers the barrier to administration and also makes remote follow-up easier. The drawbacks are limited commercial and technical transparency: pricing, integrations, permissions, and deployment details are missing. Enterprises or hospitals will need to further confirm data flows, backend management, EHR/EMR integration, and service support capabilities before procurement.
DANA is best suited for medical institutions, research teams, and digital health projects assessing conditions related to ADHD, memory issues, TBI/concussion, medication management, PTSD, sleep disorders, depression, stress, and various cognitive impairments. Access from China is unclear; payment methods and China-specific local compliance are not disclosed. For deployment in China, additional evaluation would be needed around network accessibility, cross-border data transfer, medical device registration, and local alternatives.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on danabrainvital.com official site.
danabrainvital.com is an United States Health provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach danabrainvital.com directly.